These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6539574)

  • 21. Human articular cartilage contains an inhibitor of plasminogen activator.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen activators in human malignant melanoma.
    Markus G; Kohga S; Camiolo SM; Madeja JM; Ambrus JL; Karakousis C
    J Natl Cancer Inst; 1984 Jun; 72(6):1213-22. PubMed ID: 6374238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.
    Chapman HA; Stone OL; Vavrin Z
    J Clin Invest; 1984 Mar; 73(3):806-15. PubMed ID: 6368589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assay for protease inhibitors: qualitative measurement and detection in polyacrylamide gel electrophoretograms.
    Grenier D
    J Biochem Biophys Methods; 1991 Jan; 22(1):35-40. PubMed ID: 2005358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and regulation of tissue plasminogen activator activity in rat cumulus-oocyte complexes.
    Liu YX; NY T; Sarkar D; Loskutoff D; Hsueh AJ
    Endocrinology; 1986 Oct; 119(4):1578-87. PubMed ID: 3093195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoids stimulate plasminogen activator production by rat granulosa cells.
    Wang C; Leung A
    Endocrinology; 1989 Apr; 124(4):1595-601. PubMed ID: 2784380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of protease inhibitors using substrate-containing sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
    Hanspal JS; Bushell GR; Ghosh P
    Anal Biochem; 1983 Jul; 132(2):288-93. PubMed ID: 6353999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of tumor markers in uterine cancer (plasminogen activators, plasminogen activator inhibitors) using fibrin autography].
    Itoh Y; Nozaki S; Sawaguchi K; Masuda T; Yabushita H; Noguchi M; Miyata N; Nakanishi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1277-8. PubMed ID: 1431441
    [No Abstract]   [Full Text] [Related]  

  • 30. Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells.
    Laug WE
    Thromb Haemost; 1985 Apr; 53(2):165-9. PubMed ID: 3927503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
    Philips M; Juul AG; Thorsen S
    Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrin induction of tissue plasminogen activator expression in corneal endothelial cells in vitro.
    Ramsby ML; Kreutzer DL
    Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3207-19. PubMed ID: 7691778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The course and prerequisites of Lys-plasminogen formation during fibrinolysis.
    Suenson E; Thorsen S
    Biochemistry; 1988 Apr; 27(7):2435-43. PubMed ID: 3382632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators.
    Levin EG; Loskutoff DJ
    J Cell Biol; 1982 Sep; 94(3):631-6. PubMed ID: 6813340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secretion of plasminogen activators by cultured bovine endothelial cells: partial purification, characterization and evidence for multiple forms.
    Laug WE
    Thromb Haemost; 1981 Jun; 45(3):219-24. PubMed ID: 7197062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urokinase-type and tissue-type plasminogen activators have different distributions in cultured bovine capillary endothelial cells.
    Moscatelli D
    J Cell Biochem; 1986; 30(1):19-29. PubMed ID: 3082899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue plasminogen activator inhibitor in human plasma: development of a functional assay system and demonstration of a correlating Mr = 50,000 antiactivator.
    Korninger C; Wagner O; Binder BR
    J Lab Clin Med; 1985 Jun; 105(6):718-24. PubMed ID: 3923146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S; Müllertz S; Suenson E; Kok P
    Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rat testicular peritubular cells in culture secrete an inhibitor of plasminogen activator activity.
    Hettle JA; Balekjian E; Tung PS; Fritz IB
    Biol Reprod; 1988 Mar; 38(2):359-71. PubMed ID: 2833945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor.
    Thorsen S; Philips M
    Biochim Biophys Acta; 1984 Nov; 802(1):111-8. PubMed ID: 6435684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.